Synthomer (LON:SYNT) Stock Price Crosses Below 200-Day Moving Average – Should You Sell?

Synthomer plc (LON:SYNTGet Free Report) shares crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 243.55 ($3.07) and traded as low as GBX 170 ($2.14). Synthomer shares last traded at GBX 174 ($2.19), with a volume of 241,692 shares changing hands.

Analyst Upgrades and Downgrades

SYNT has been the topic of several analyst reports. Berenberg Bank lowered their price objective on Synthomer from GBX 375 ($4.73) to GBX 340 ($4.28) and set a “buy” rating on the stock in a research report on Tuesday, August 13th. Canaccord Genuity Group dropped their price objective on Synthomer from GBX 300 ($3.78) to GBX 275 ($3.47) and set a “buy” rating on the stock in a research report on Friday, October 4th.

View Our Latest Research Report on Synthomer

Synthomer Stock Up 1.6 %

The company has a market capitalization of £284.61 million, a PE ratio of -285.25, a price-to-earnings-growth ratio of -0.17 and a beta of 1.79. The company’s fifty day moving average is GBX 195.06 and its 200-day moving average is GBX 243.55. The company has a debt-to-equity ratio of 77.42, a quick ratio of 0.97 and a current ratio of 1.90.

About Synthomer

(Get Free Report)

Synthomer plc operates as a specialty chemicals company in the United Kingdom and internationally. It operates through five segments: Performance Elastomers, Functional Solutions, Industrial Specialities, Acrylate Monomers, and Adhesive Technologies. The company offers adhesives, including PSA labels, packaging and specialty tapes, saturants, release coatings, wood working, wet glues, hygiene and contact adhesives, packaging and assembly hot melt adhesives; coatings products such as architectural, masonry, intumescent, metal, wood, soil releases, blinders, ink receptive, polyester for powder coatings, SYNTHOMER NX for coalescing agents, and SYNOLOX BEPF for glycol.

Featured Stories

Receive News & Ratings for Synthomer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synthomer and related companies with MarketBeat.com's FREE daily email newsletter.